This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Helen Elizabeth Williams: Innovator in Chemical Compounds
Introduction
Helen Elizabeth Williams is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of chemical compounds, holding a total of 3 patents. Her work focuses on the development of pharmaceutical compositions that address critical health issues.
Latest Patents
Helen's latest patents involve innovative chemical compounds. The inventions concern compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R to R have specific meanings defined in the description. These compounds are crucial for processes related to their preparation and their use in the treatment of cell proliferative disorders.
Career Highlights
Helen is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Helen has collaborated with notable professionals, including Robert Hugh Bradbury and David Buttar. These collaborations have further enhanced her research and innovation in the field.
Conclusion
Helen Elizabeth Williams is a distinguished inventor whose work in chemical compounds has the potential to impact the treatment of various health conditions. Her contributions to AstraZeneca AB and her collaborations with esteemed colleagues underscore her importance in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile